RESUMEN
Objective To observe the clinical curative effect and adverse reaction of Zilongjin Tablets in the treatment of advanced malignant tumor. Methods Fifty-three patients were treated with Zilongjin Tablets orally in the treatment group based on routine treatment, while 52 patients in the control group were treated only with conventional treatment. Each group was treated for two courses (28 d). Results The clinical response cases of stable disease in the short-term efficacy of the treatment group were more than that in the control group (P < 0.05). In the meanwhile, the life quality improvement was better than that of the control group (P < 0.01). Conclusion Zilongjin Tablets showed a better curative effect in the treatment of advanced malignant neoplasms without obvious adverse reaction.